| Series |
Advances and Controversies in Hematopoietic Transplantation and Cell Therapy, 2569-1376
Advances and controversies in hematopoietic transplantation and cell therapy. ^A1421797
|
| Contents |
Intro -- Contents -- 1: Introduction to First Edition: Progress in Supportive Care Medicine and Hematopoietic Cell Transplant and Cellular Therapy -- References -- 2: Palliative Care for the Hematopoietic Cell Transplant and Cellular Therapy Clinician -- 2.1 Introduction -- 2.2 Unmet Palliative Care Needs in Patients with Hematologic Malignancies -- 2.3 Defining Palliative Care -- 2.4 The Benefits of Palliative Care -- 2.5 Conceptual Model of Palliative Care in Hematologic Malignancies -- 2.6 Barriers to Palliative Care Integration in Hematologic Malignancies |
| Contents |
2.7 Strategies to Optimize Integration/Expert Point of View -- 2.8 Future Directions -- References -- 3: Recognition and Management of Transplant-Related Aches and Pain Issues -- 3.1 Introduction -- 3.2 General Assessment of a Patient with Pain -- 3.3 Types of Pain -- 3.3.1 Nociceptive Pain -- 3.4 Pharmacologic Treatment of Pain -- 3.5 Non-opioid Adjuvant Medications -- 3.5.1 Opioids -- 3.6 Side Effects of Opioids -- 3.7 Neuropathic Pain -- 3.8 Neuropathic Agents -- 3.9 Non-pharmacological Treatments -- 3.10 Careful Considerations in Transplant Recipients |
| Contents |
3.11 Expert Recommendations -- References -- 4: Transplant-Related Non-pain Issues: Prevention, Intervention, and Limitations -- 4.1 Introduction -- 4.2 Fatigue -- 4.2.1 Measuring Cancer-Related Fatigue -- 4.2.2 Causes of Fatigue and Interventions -- 4.3 Delirium -- 4.3.1 Intervention: Non-Pharmacologic -- 4.3.2 Intervention: Pharmacologic -- 4.4 Malnutrition/Anorexia -- 4.4.1 Management of Cancer Malnutrition -- 4.5 Mucositis -- 4.5.1 Prevention and Treatment of Oral Mucositis -- 4.5.2 Pain Control -- 4.5.3 Nutritional Support -- 4.6 Nausea and Vomiting -- 4.6.1 5-HT3 Inhibitors |
| Contents |
4.6.2 NK1R Inhibitors -- 4.6.3 Glucocorticoids -- 4.6.4 Olanzapine -- 4.6.5 Other Agents -- 4.7 Diarrhea -- 4.7.1 Graft-Versus-Host Disease -- 4.7.2 Non-oral Mucositis -- 4.7.3 Infections -- 4.7.4 Neutropenic Enterocolitis (Typhlitis) -- 4.7.5 Cord Colitis Syndrome -- 4.8 Constipation -- 4.8.1 Laxatives -- 4.8.2 Opioid Antagonists -- 4.9 Summary -- References -- 5: Pre-transplant Comorbidities: Influence on Decision-Making and Outcomes -- 5.1 Introduction -- 5.2 Historical Efforts to Correlate Comorbidities with Transplant Outcomes |
| Contents |
5.3 Development of the HCT-Specific Comorbidity Index -- 5.3.1 Validation -- 5.4 How to Implement the HCT-CI Model -- 5.5 Impact of HCT-CI and Comorbidities on Transplant Outcomes -- 5.6 Expansion of the HCT-CI -- 5.6.1 Augmented HCT-CI Score -- 5.6.2 Composite Comorbidity/Age Index -- 5.6.3 Composite HCT-CI Score and Karnofsky Performance Status -- 5.6.4 Composite HCT-CI and European Society for Blood and Marrow Transplantation Score -- 5.6.5 Combined HCT-CI Score and the Instrumental Activities of Daily Living Assessment -- 5.6.6 Combined Comorbidity/Relapse Model |
| Abstract |
This book provides up-to-date, clinically relevant information on a range of complex issues relating to supportive care strategies for the recipients of hematopoietic cell transplantation. The topics addressed include the prevention, recognition, and treatment of transplant-related side effects; management of pretransplant comorbidities; supportive care for specific age groups; quality of life issues in patients who experience graft-versus-host disease; mental and spiritual health care; caregiver and healthcare provider support strategies; and important issues related to end of life care. The aim is to supply hematologists, oncologists, transplant specialists, and palliative care physicians with practical knowledge that can be immediately applied in patient care to optimize transplant-related outcomes. The book's format, which offers concise, non-exhaustive coverage of these and other unique topics, is supplemented by a wealth of working tables, algorithms, and figures, ensuring that it will also serve hematology, oncology and transplant trainees as a reliable companion during their daily work. The authors are world-renowned experts in the field of hematopoietic transplantation and palliative care medicine, and present well-reasoned opinions based on their own experiences and draw attention to relevant results from potentially high-impact clinical trials. |
| Bibliography note | Includes bibliographical references. |
| Source of description | Description based on online resource; title from digital title page (viewed on December 14, 2020). |
| Issued in other form | Print version: Finn, Laura Supportive Care Strategies : Optimizing Transplant Care Cham : Springer International Publishing AG,c2020 9783319590134 |
| Genre/form | Electronic books. |
| ISBN | 9783319590141 electronic book |
| ISBN | 3319590146 electronic book |
| Standard identifier# |
10.1007/978-3-319-59014-1 |
| Stock number | com.springer.onix.9783319590141 Springer Nature |
